Read the original here: ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions
Read the original here: ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions
Read more from the original source: MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
See more here: Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen
See the original post: First Patient Dosed in Phase II Trial to Treat Complications in COVID-19
Read the original post: Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe
Read more: Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol
Follow this link: Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock
See the rest here: Theratechnologies Appoints Two New Board Members
Go here to see the original: Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
Read the rest here: Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome
Recent Comments